Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach
{{output}}
Cancer therapy is a dynamically evolving field, witnessing the emergence of innovative approaches that offer a promising outlook for patients grappling with persistent disease. Within the realm of therapeutic exploration, chimeric antigen receptor (CAR) T cell... ...
